Bill would require senior living communities to recognize essential caregivers … Home oxygen groups request continued flexibilities at PHE’s end … Medicare enrollment has surged among kidney failure...
Clinical briefs for Tuesday, Nov. 17
By
Alicia Lasek
Nov 17, 2020
LTC pharmacies lament financial distress, request pandemic relief … 421,000 COVID tests headed to assisted living communities from the federal government … Watch for dangerous atrial fibrillation...
New CDC vaccine access info covers COVID booster shots, ‘safety net’ support
By
Alicia Lasek
Sep 23, 2021
With assurances to provide help as needed, the Centers of Disease Control and Prevention is sharing vaccine access information ahead of the federal COVID-19 vaccine booster shot approvals expected to come...
CDC: Lasting COVID-19 symptoms tied to age, sex, race factors
By
Alicia Lasek
Sep 21, 2021
Investigators examined recovered COVID-19 patients in Long Beach California. Fully one third of participants reported having at least one symptom of post-acute sequelae, commonly called “long COVID-19,”...
Feds to reimburse providers for counseling patients to self-isolate
By
Alicia Lasek
Jul 31, 2020
Existing E/M codes can be used to bill for counseling patients about virus mitigation at the time of COVID-19 testing, according to CMS and the CDC.
All nursing home staff in Massachusetts must get COVID-19 shots
By
Alicia Lasek
Aug 05, 2021
The state is requiring staff and contract employees in all of its 378 facilities to receive a vaccination, Gov. Charlie Baker announced Wednesday.
CDC director: Agency working to ensure flu vaccine availability
By
Alicia Lasek
Jun 04, 2020
The agency is working with drugmakers to help head off what it says could be an overwhelming wave of flu and COVID-19 infections this fall.
Fauci: Early data show omicron spreads quickly but with less severity than delta
By
Alicia Lasek
Dec 08, 2021
Omicron cases appear to have led to fewer hospitalizations and patients have been less likely to need oxygen, the White House’s infectious disease expert said Tuesday.
FDA nixes use of Parkinson’s drug Nuplazid for treating Alzheimer’s psychosis
By
Alicia Lasek
Aug 08, 2022
The Food and Drug Administration has decided not to approve an expanded use of the psychosis drug pimavanserin (Nuplazid) to treat patients with Alzheimer’s.
Alzheimer’s drug donanemab finds late-stage trial success, safety concerns
By
Alicia Lasek
May 04, 2023
The experimental drug donanemab appears to halt the progression of Alzheimer’s disease and slow certain measures of clinical decline, new trial data show.